Cancer Gene Therapy

Article	Citations
Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms	423
Key chemokines direct migration of immune cells in solid tumors	179
Cancer-associated fibroblasts: overview, progress, challenges, and directions	153
Transcription factors in ferroptotic cell death	135
Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death	124
METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway	95
TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials	87
The KRAS-G12C inhibitor: activity and resistance	61
ESCRT-III-mediated membrane repair in cell death and tumor resistance	52
LOX-1 and cancer: an indissoluble liaison	49
Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study	47
HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer	47
Nanomedicine-based cancer immunotherapy: recent trends and future perspectives	42
Roles of miRNA dysregulation in the pathogenesis of multiple myeloma	39
Expression pattern of m6A regulators is significantly correlated with malignancy and antitumor immune response of breast cancer	38
Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p/HAS2 axis	37
Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance	36
Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy	34
Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy	34
CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model	33
TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential	33
Oncolytic adenoviruses synergistically enhance anti-PD-L1 and anti-CTLA-4 immunotherapy by modulating the tumour microenvironment in a 4T1 orthotopic mouse model	32
Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma	31
Extracellular vesicles-encapsulated microRNA-10a-5p shed from cancer-associated fibroblast facilitates cervical squamous cell carcinoma cell angiogenesis and tumorigenicity via Hedgehog signaling path	29
GINS2 promotes EMT in pancreatic cancer via specifically stimulating ERK/MAPK signaling	28

LncRNA LINC01857 promotes cell growth and diminishes apoptosis via PI3K/mTOR pathway and EMT process by regulating miR-141-3p/MAP4K4 axis in diffuse large B-cell lymphoma	27
Cytokine-enhanced cytolytic activity of exosomes from NK Cells	27
Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy	26
LncRNA KCNQ1OT1 facilitates the progression of bladder cancer by targeting MiR-218-5p/HS3ST3B1	25
circSFMBT1 promotes pancreatic cancer growth and metastasis via targeting miR-330-5p/PAK1 axis	25
Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours	25
MicroRNA-375 represses tumor angiogenesis and reverses resistance to sorafenib in hepatocarcinoma	24
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40	24
Recent updates on chimeric antigen receptor T cell therapy for hepatocellular carcinoma	23
Elevating microRNA-1-3p shuttled by cancer-associated fibroblasts-derived extracellular vesicles suppresses breast cancer progression and metastasis by inhibiting GLIS1	22
YY1-mediated long non-coding RNA Kcnq1ot1 promotes the tumor progression by regulating PTEN via DNMT1 in triple negative breast cancer	22
The V-ATPases in cancer and cell death	22
Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy	21
Protein post-translational modifications in the regulation of cancer hallmarks	21
Long non-coding RNA HAND2-AS1 delays cervical cancer progression via its regulation on the microRNA-21-5p/TIMP3/VEGFA axis	21
LincRNA-ROR is activated by H3K27 acetylation and induces EMT in retinoblastoma by acting as a sponge of miR-32 to activate the Notch signaling pathway	21
The changing face of gastric cancer: epidemiologic trends and advances in novel therapies	21
Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy	21
MicroRNA binding site polymorphism in inflammatory genes associated with colorectal cancer: literature review and bioinformatics analysis	21
EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma	21
LncRNA HLA-F-AS1 promotes colorectal cancer metastasis by inducing PFN1 in colorectal cancer-derived extracellular vesicles and mediating macrophage polarization	21
Extracellular sialyltransferase st6gal1 in breast tumor cell growth and invasiveness	21
PRMT5: a putative oncogene and therapeutic target in prostate cancer	20
Fatty acid β-oxidation promotes breast cancer stemness and metastasis via the miRNA-328-3p-CPT1A pathway	19
Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation	19
FOXO3-induced lncRNA LOC554202 contributes to hepatocellular carcinoma progression via the miR-485-5p/BSG axis	19
circRACGAP1 promotes non-small cell lung cancer proliferation by regulating miR-144-5p/CDKL1 signaling pathway	19
SNHG17/miR-384/ELF1 axis promotes cell growth by transcriptional regulation of CTNNB1 to activate Wnt/β-catenin pathway in oral squamous cell carcinoma	18
Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis	18
Vector engineering, strategies and targets in cancer gene therapy	18
Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety	18
LncRNAs in breast cancer: a link to future approaches	18
Lipid-related FABP5 activation of tumor-associated monocytes fosters immune privilege via PD-L1 expression on Treg cells in hepatocellular carcinoma	17
Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand	17
Delivery technologies to engineer natural killer cells for cancer immunotherapy	17
An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway	17
Post-translational modifications of tubulin: their role in cancers and the regulation of signaling molecules	17
RHPN1-AS1 promotes cell proliferation and migration via miR-665/Akt3 in ovarian cancer	17
Heat shock protein-90alpha (Hsp90α) stabilizes hypoxia-inducible factor-1α (HIF-1α) in support of spermatogenesis and tumorigenesis	17
Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma	16
LncRNA MAGI2-AS3 inhibits tumor progression and angiogenesis by regulating ACY1 via interacting with transcription factor HEY1 in clear cell renal cell carcinoma	16
Long non-coding RNA LINC02446 suppresses the proliferation and metastasis of bladder cancer cells by binding with EIF3G and regulating the mTOR signalling pathway	15
Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes	15
SMURF1, a promoter of tumor cell progression?	15
Genetically engineered mesenchymal stem cells: targeted delivery of immunomodulatory agents for tumor eradication	15
microRNA-let-7e in serum-derived exosomes inhibits the metastasis of non-small-cell lung cancer in a SUV39H2/LSD1/CDH1-dependent manner	15
Recent advances in immune therapies for gastric cancer	15
LncRNA UCA1 promotes SOX12 expression in breast cancer by regulating m6A modification of miR-375 by METTL14 through DNA methylation	14
Mutant KRAS drives metabolic reprogramming and autophagic flux in premalignant pancreatic cells	14
Circular RNA FLNA acts as a sponge of miR-486-3p in promoting lung cancer progression via regulating XRCC1 and CYP1A1	14

LncRNA MAFG-AS1 promotes the malignant phenotype of ovarian cancer by upregulating NFKB1-dependent IGF1	14
Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling	14
Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy	14
LncRNA KCNQ1OT1 regulates the invasion and migration of hepatocellular carcinoma by acting on S1PR1 through miR-149	14
BATF3 promotes malignant phenotype of colorectal cancer through the S1PR1/p-STAT3/miR-155-3p/WDR82 axis	14
LncRNA ANCR promotes glioma cells invasion, migration, proliferation and inhibits apoptosis via interacting with EZH2 and repressing PTEN expression	14
Viroimmunotherapy for breast cancer: promises, problems and future directions	13
LncRNA SNHG5 promotes the proliferation and cancer stem cell-like properties of HCC by regulating UPF1 and Wnt-signaling pathway	13
LINC00337 promotes tumor angiogenesis in colorectal cancer by recruiting DNMT1, which suppresses the expression of CNN1	13
Circular RNA hsa_circ_0009172 suppresses gastric cancer by regulation of microRNA-485-3p-mediated NTRK3	13
Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma	13
m6A-modified circFOXK2 targets GLUT1 to accelerate oral squamous cell carcinoma aerobic glycolysis	13
Downregulation of SBF2-AS1 functions as a tumor suppressor in clear cell renal cell carcinoma by inhibiting miR-338-3p-targeted ETS1	13
SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells	13
The LncRNA RP11-301G19.1/miR-582-5p/HMGB2 axis modulates the proliferation and apoptosis of multiple myeloma cancer cells via the PI3K/AKT signalling pathway	12
Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer	12
c-Jun N-terminal kinase 2 suppresses pancreatic cancer growth and invasion and is opposed by c-Jun N-terminal kinase 1	12
RETRACTED ARTICLE: circ_001504 promotes the development of renal cell carcinoma by sponging microRNA-149 to increase NUCB2	12
Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis	12
Decellularized normal and cancer tissues as tools for cancer research	12
m6A demethylase ALKBH5 promotes tumor cell proliferation by destabilizing IGF2BPs target genes and worsens the prognosis of patients with non-small-cell lung cancer	12
Mechanisms of drug resistance mediated by long non-coding RNAs in non-small-cell lung cancer	12
Clinical trials of self-replicating RNA-based cancer vaccines	12
Silencing long noncoding RNA colon cancer-associated transcript-1 upregulates microRNA-34a-5p to promote proliferation and differentiation of osteoblasts in osteoporosis	12
A new immunotherapy strategy targeted CD30 in peripheral T-cell lymphomas: CAR-modified T-cell therapy based on CD30 mAb	12
Enhanced antitumor immune response in melanoma tumor model by anti-PD-1 small interference RNA encapsulated in nanoliposomes	12
miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer	12
CircRNA circ_0006156 inhibits the metastasis of prostate cancer by blocking the ubiquitination of S100A9	12
TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas	12
UNC5B mediates G2/M phase arrest of bladder cancer cells by binding to CDC14A and P53	11
Tumor suppressor immune gene therapy to reverse immunotherapy resistance	11
MicroRNA-766-3p-mediated downregulation of HNF4G inhibits proliferation in colorectal cancer cells through the PI3K/AKT pathway	11
Inhibition of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived from a de novo murine brain cancer model	11
Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of origin	11
METTL3-mediated N6-methyladenosine modification of DUSP5 mRNA promotes gallbladder-cancer progression	11
Safety of Adeno-associated virus-based vector-mediated gene therapy—impact of vector dose	11
NEAT1 in bone marrow mesenchymal stem cell-derived extracellular vesicles promotes melanoma by inducing M2 macrophage polarization	11
Human umbilical cord blood mesenchymal stem cells-derived exosomal microRNA-503-3p inhibits progression of human endometrial cancer cells through downregulating MEST	11
Cannabinoids orchestrate cross-talk between cancer cells and endothelial cells in colorectal cancer	11
Inhibition of host Ogr1 enhances effector CD8+ T-cell function by modulating acidic microenvironment	11
Downregulation of miR-335 exhibited an oncogenic effect via promoting KDM3A/YAP1 networks in clear cell renal cell carcinoma	11
Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling	11
The LIN28B/TGF-β/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinoma	10
LSD1-mediated stabilization of SEPT6 protein activates the TGF-β1 pathway and regulates non-small-cell lung cancer metastasis	10
New targeted and epigenetic therapeutic strategies for the treatment of uveal melanoma	10
Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer	10
YAP 5-methylcytosine modification increases its mRNA stability and promotes the transcription of exosome secretion-related genes in lung adenocarcinoma	10
Long non-coding RNA FOXD3-AS1 silencing exerts tumor suppressive effects in nasopharyngeal carcinoma by downregulating FOXD3 expression via microRNA-185-3p upregulation	10
LncRNA LINC00649 recruits TAF15 and enhances MAPK6 expression to promote the development of lung squamous cell carcinoma via activating MAPK signaling pathway	10
CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells	10
The molecular underpinning of geminin-overexpressing triple-negative breast cancer cells homing specifically to lungs	10
Molecular mechanism of miR-34b-5p and RNA binding protein HuR binding to lncRNA OIP5-AS1 in colon cancer cells	10
DNA-double strand breaks enhance the expression of major histocompatibility complex class II through the ATM-NF-κΒ-IRF1-CIITA pathway	10
EZH1/2 as targets for cancer therapy	10
RETRACTED ARTICLE: microRNA-211-mediated targeting of the INHBA-TGF-β axis suppresses prostate tumor formation and growth	10
DRAIC promotes growth of breast cancer by sponging miR-432-5p to upregulate SLBP	10
Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies	9
Use of an optimised enzyme/prodrug combination for Clostridia directed enzyme prodrug therapy induces a significant growth delay in necrotic tumours	9
Bone marrow stromal cells-derived microRNA-181-containing extracellular vesicles inhibit ovarian cancer cell chemoresistance by downregulating MEST via the Wnt/β-catenin signaling pathway	9
In vivo antitumor activity by dual stromal and tumor-targeted oncolytic measles viruses	9
Genomic alterations caused by HPV integration in a cohort of Chinese endocervical adenocarcinomas	9
CDK4/6-USP51 axis regulates lung adenocarcinoma metastasis through ZEB1	9
Oncolytic adenovirus encoding LIGHT (TNFSF14) inhibits tumor growth via activating anti-tumor immune responses in 4T1 mouse mammary tumor model in immune competent syngeneic mice	9
Analysis of the mutational status of SIX1/2 and microRNA processing genes in paired primary and relapsed Wilms tumors and association with relapse	9
Correction: Cancer-associated fibroblasts: overview, progress, challenges, and directions	9
Recent progress in exosome research: isolation, characterization and clinical applications	9
The application of CRISPR/Cas9 system in cervical carcinogenesis	9
CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapy	9
Cancer immunotherapies revisited: state of the art of conventional treatments and next-generation nanomedicines	9
ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis	9
Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways	9
Intratumoral DNA-based delivery of checkpoint-inhibiting antibodies and interleukin 12 triggers T cell infiltration and anti-tumor response	9
RETRACTED ARTICLE: Silencing of long non-coding RNA XIST represses gastric cancer progression through blocking NFκB pathway via inhibiting HNF4A-mediated transcription of EPHA1	9
microRNA-9-5p regulates the mitochondrial function of hepatocellular carcinoma cells through suppressing PDK4	9
Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting	8
Flotillin-1 palmitoylation turnover by APT-1 and ZDHHC-19 promotes cervical cancer progression by suppressing IGF-1 receptor desensitization and proteostasis	8
Overexpression of microRNA-130a represses uveal melanoma cell migration and invasion through inactivation of the Wnt/β-catenin signaling pathway by downregulating USP6	8
Global characterization of megakaryocytes in bone marrow, peripheral blood, and cord blood by single-cell RNA sequencing	8
Therapeutic anti-glioma effect of the combined action of PCSK inhibitor with the anti-tumoral factors secreted by Poly (I:C)-stimulated macrophages	8
Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer	8

Targeting GNAQ/11 through PKC inhibition in uveal melanoma	8
Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-β pathway	8
Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis	8
RETRACTED ARTICLE: Long non-coding RNA DIO3OS binds to microRNA-130b to restore radiosensitivity in esophageal squamous cell carcinoma by upregulating PAX9	8
Involvement of CDK11B-mediated SPDEF ubiquitination and SPDEF-mediated microRNA-448 activation in the oncogenicity and self-renewal of hepatocellular carcinoma stem cells	8
The future of microfluidics in immune checkpoint blockade	8
Streptococcal bacterial components in cancer therapy	7
Silencing TRAIP suppresses cell proliferation and migration/invasion of triple negative breast cancer via RB-E2F signaling and EMT	7
KRAS-related long noncoding RNAs in human cancers	7
DNA-based delivery of anti-DR5 Nanobodies improves exposure and anti-tumor efficacy over protein-based administration	7
Next generation self-replicating RNA vectors for vaccines and immunotherapies	7
LEDGF/p75-mediated chemoresistance of mixed-lineage leukemia involves cell survival pathways and super enhancer activators	7
Cancer vaccine strategies using self-replicating RNA viral platforms	7
MiR-181c sensitizes ovarian cancer cells to paclitaxel by targeting GRP78 through the PI3K/Akt pathway	7
Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p/SOX9 axis through PI3K/AKT pathway	7
LINC00671 suppresses cell proliferation and metastasis in pancreatic cancer by inhibiting AKT and ERK signaling pathway	7
Long noncoding RNA LINC01291 promotes the aggressive properties of melanoma by functioning as a competing endogenous RNA for microRNA-625-5p and subsequently increasing IGF-1R expression	7
Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients	7
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia	7
Exosomal HMGA2 protein from EBV-positive NPC cells destroys vascular endothelial barriers and induces endothelial-to-mesenchymal transition to promote metastasis	7
FAP is critical for ovarian cancer cell survival by sustaining NF-κB activation through recruitment of PRKDC in lipid rafts	7
LIPG: an inflammation and cancer modulator	7
RETRACTED ARTICLE: Targeting KDM1B-dependent miR-215-AR-AGR2-axis promotes sensitivity to enzalutamide-resistant prostate cancer	7
TAF1A and ZBTB41 serve as novel key genes in cervical cancer identified by integrated approaches	7
Stabilizing and upregulating Axin with tankyrase inhibitor reverses 5-fluorouracil chemoresistance and proliferation by targeting the WNT/caveolin-1 axis in colorectal cancer cells	6
Combination regimen of granulocyte colony-stimulating factor and recombinant human thrombopoietin improves the curative effect on elderly patients with leukemia through inducing pyroptosis and ferropt	6
The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth	6
circPTPN22 attenuates immune microenvironment of pancreatic cancer via STAT3 acetylation	6
γ-Glutamylcyclotransferase, a novel regulator of HIF-1α expression, triggers aerobic glycolysis	6
Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models	6
LncRNA-NEF suppressed oxaliplatin resistance and epithelial-mesenchymal transition in colorectal cancer through epigenetically inactivating MEK/ERK signaling	6
Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1	6
FUT6 inhibits the proliferation, migration, invasion, and EGF-induced EMT of head and neck squamous cell carcinoma (HNSCC) by regulating EGFR/ERK/STAT signaling pathway	6
Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease	6
MicroRNA-21 guide and passenger strand regulation of adenylosuccinate lyase-mediated purine metabolism promotes transition to an EGFR-TKI-tolerant persister state	6
ERRα coordinates actin and focal adhesion dynamics	6
Overexpressed sFRP3 exerts an inhibitory effect on hepatocellular carcinoma via inactivation of the Wnt/β-catenin signaling pathway	6
Engineered cells as glioblastoma therapeutics	6
Silencing of RND3/RHOE inhibits the growth of human hepatocellular carcinoma and is associated with reversible senescence	6
P38 kinase in gastrointestinal cancers	6
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation	6
Tumor-suppressive microRNA-551b-3p targets H6PD to inhibit gallbladder cancer progression	6
Non-classical Notch signaling by MDA-MB-231 breast cancer cell-derived small extracellular vesicles promotes malignancy in poorly invasive MCF-7 cells	6
Autophagy inhibition is the next step in the treatment of glioblastoma patients following the Stupp era	6
Claudin-1/4 as directly target gene of HIF-1α can feedback regulating HIF-1α by PI3K-AKT-mTOR and impact the proliferation of esophageal squamous cell though Rho GTPase and p-JNK pathway	6
LncNAP1L6 activates MMP pathway by stabilizing the m6A-modified NAP1L2 to promote malignant progression in prostate cancer	6
LncSNHG14 promotes nutlin3a resistance by inhibiting ferroptosis via the miR-206 /SLC7A11 axis in osteosarcoma cells	6
Pharmacological targeting of CBP/p300 drives a redox/autophagy axis leading to senescence-induced growth arrest in non-small cell lung cancer cells	6
Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers	6
Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4	6
RETRACTED ARTICLE: CREB3L4 promotes angiogenesis and tumor progression in gastric cancer through regulating VEGFA expression	6
ARID2 suppression promotes tumor progression and upregulates cytokeratin 8, 18 and β-4 integrin expression in TP53-mutated tobacco-related oral cancer and has prognostic implications	5
STAT3 regulates miR93-mediated apoptosis through inhibiting DAPK1 in renal cell carcinoma	5
HIF-1α/IL-8 axis in hypoxic macrophages promotes esophageal cancer progression by enhancing PD-L1 expression	5
Correction: MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer	5
The prognostic value of circular RNA regulatory genes in competitive endogenous RNA network in gastric cancer	5
Targeting histone deacetylases for combination therapies in neuroendocrine tumors	5
Improvement of muscular atrophy by AAV–SaCas9-mediated myostatin gene editing in aged mice	5
Identification of an immune gene-associated prognostic signature in patients with bladder cancer	5
PDLIM2 prevents the malignant phenotype of hepatocellular carcinoma cells by negatively regulating β-catenin	5
Lysine-40 succinylation of TAGLN2 induces glioma angiogenesis and tumor growth through regulating TMSB4X	5
The tumor-suppressive role of microRNA-873 in nasopharyngeal carcinoma correlates with downregulation of ZIC2 and inhibition of AKT signaling pathway	5
Regulation of tumor metabolism by post translational modifications on metabolic enzymes	5
Membrane linked RNA glycosylation as new trend to envision epi-transcriptome epoch	5
Hedyotis diffusae Herba-Andrographis Herba inhibits the cellular proliferation of nasopharyngeal carcinoma and triggers DNA damage through activation of p53 and p21	5
Glioma pathogenesis-related protein 1 performs dual functions in tumor cells	5
Suppression of tumor growth and metastasis in Shkbp1 knockout mice	5
Acute myeloid leukemia cell-derived extracellular vesicles carrying microRNA-548ac regulate hematopoietic function via the TRIM28/STAT3 pathway	5
SON inhibits megakaryocytic differentiation via repressing RUNX1 and the megakaryocytic gene expression program in acute megakaryoblastic leukemia	5
Use of CRISPR-based screens to identify mechanisms of chemotherapy resistance	5
KDM3B-ETF1 fusion gene downregulates LMO2 via the WNT/β-catenin signaling pathway, promoting metastasis of invasive ductal carcinoma	5
Description and optimization of a multiplex bead-based flow cytometry method (MBFCM) to characterize extracellular vesicles in serum samples from patients with hematological malignancies	5
Extracellular vesicles released by glioma cells are decorated by Annexin A2 allowing for cellular uptake via heparan sulfate	5
FTO promotes Bortezomib resistance via m6A-dependent destabilization of SOD2 expression in multiple myeloma	5
Human umbilical vein endothelial cells-derived microRNA-203-containing extracellular vesicles alleviate non-small-cell lung cancer progression through modulating the DTL/p21 axis	5
β3-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma	5
Therapeutic utility of engineered myeloid cells in the tumor microenvironment	5
Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis	5
Regional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibition	4
C3a and C5a facilitates the metastasis of myeloma cells by activating Nrf2	4
RETRACTED ARTICLE: Downregulation of microRNA-324-3p inhibits lung cancer by blocking the NCAM1-MAPK axis through ALX4	4
Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent m	4
A comprehensive understanding of hnRNP A1 role in cancer: new perspectives on binding with noncoding RNA	4
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin	4
NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma	4
Regulation of melanoma malignancy by the RP11-705C15.3/miR-145-5p/NRAS/MAPK signaling axis	4
The cross-talk of cancer-associated fibroblasts assist in prognosis and immunotherapy in patients with breast carcinoma	4
Inhibition of myeloid PD-L1 suppresses osteoclastogenesis and cancer bone metastasis	4
Role of non-coding RNAs in neuroblastoma	4
Elevated GIGYF2 expression suppresses tumor migration and enhances sensitivity to temozolomide in malignant glioma	4
Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma	4
HUWE1 cooperates with RAS activation to control leukemia cell proliferation and human hematopoietic stem cells differentiation fate	4
Protooncogene MYC drives human melanocyte melanogenesis and senescence	4
PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma	4
SUMOylation inhibition enhances multiple myeloma sensitivity to lenalidomide	4